about
Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease.Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient.Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.Administration of budesonide in children with graft-versus-host disease.Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis.Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis.Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma.Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype-phenotype correlation.Shwachman-Diamond Syndrome: frequent misdiagnosis as Jeune Syndrome and other peculiaritiesHematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 studyCombined use of ruxolitinib and sirolimus: increased monitoring of triglycerides required
P50
Q41522160-41B48D37-736A-4648-A937-40A42BE4C4A0Q43110026-117427BC-9A99-47C2-97CC-2E899E6B8DD6Q44202286-4DE4387A-4992-49E1-B5D9-4A678C5AE2D3Q45413952-3A1EA0BE-4E6C-4789-937F-1EC149DE858EQ46519541-B60DC603-D7E4-437D-8CC7-88416FF84AEFQ49033326-97A8A78A-8A8B-4537-A11B-91C83FD27B0DQ49074524-BB2C2CA2-AF0F-4D70-871A-945A840908F2Q49107191-18E58871-76E0-472B-A40F-B4A268B1DA68Q49108669-3C650840-CA86-4104-871E-C93A3DB88D32Q49121160-E7AE9C11-25A8-41D5-B056-180D9A1BB5A5Q49121642-79FC96E7-586B-488C-99DD-62A66F04CD60Q49160060-2F6C9BD1-F04E-4E40-867F-E2FEB922319BQ52917965-D5FF6BA2-B413-4EFB-A738-BF9F6D955995Q59268786-6AD2A3BD-115F-44DE-96BB-3C28FE5A7BA3Q59537977-8C9B0F16-FE2B-4E0C-B860-984D6079F22FQ91907363-E7F1A476-5D86-4FAB-A462-2E50C8099EA4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Victoria Bordon
@en
Victoria Bordon
@nl
type
label
Victoria Bordon
@en
Victoria Bordon
@nl
prefLabel
Victoria Bordon
@en
Victoria Bordon
@nl
P31
P496
0000-0001-8446-0220